Sign in
4

Changes in Ownership

PROTHENA CORP PUBLIC LTD CO Filed Acc 0001140361-23-040143

Chief Medical Officer sold 2,000 shares at an average $58.74 ($117,480)

  • Chief Medical Officer acquired 2,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Garren Hideki Chief Medical Officer 2023-08-16 Option exercise 10b5-1 +2,000 $24.90 $49,800 2,000 D
Garren Hideki Chief Medical Officer 2023-08-16 Sale 10b5-1 −878 $58.15 $51,059 1,122 D
Garren Hideki Chief Medical Officer 2023-08-16 Sale 10b5-1 −748 $58.93 $44,079 374 D
Garren Hideki Chief Medical Officer 2023-08-16 Sale 10b5-1 −374 $59.74 $22,341 0 D
Derivatives
Garren Hideki Chief Medical Officer 2023-08-16 Option exercise · Stock Option (Right to Buy) 10b5-1 −2,000 194,000 D
Open-market sales · 2,000 sh · avg $58.74 · $117,480
Loading xslF345X05/form4.xml…